Published in Clin Infect Dis on January 01, 2003
Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection. AIDS (2007) 1.95
Prospective study of bone mineral density changes in aging men with or at risk for HIV infection. AIDS (2010) 1.06
Gonadal and Adrenal Abnormalities in Drug Users: Cause or Consequence of Drug Use Behavior and Poor Health Outcomes. Am J Infect Dis (2006) 0.88
Prospective evaluation of bone mineral density among middle-aged HIV-infected and uninfected women: Association between methadone use and bone loss. Maturitas (2011) 0.85
Aging and HIV infection. J Urban Health (2006) 0.85
Opiate dependence as an independent and interactive risk factor for arterial stiffness and cardiovascular ageing - a longitudinal study in females. J Clin Med Res (2013) 0.82
Hypogonadism in human immunodeficiency virus-positive men. Korean J Urol (2014) 0.81
Reduction in arterial stiffness and vascular age by naltrexone-induced interruption of opiate agonism: a cohort study. BMJ Open (2013) 0.79
Impact of lifetime opioid exposure on arterial stiffness and vascular age: cross-sectional and longitudinal studies in men and women. BMJ Open (2014) 0.78
Lifetime and recent alcohol use and bone mineral density in adults with HIV infection and substance dependence. Medicine (Baltimore) (2017) 0.75
Epidemiologic and molecular pathophysiology of chronic opioid dependence and the place of naltrexone extended-release formulations in its clinical management. Subst Abuse (2012) 0.75
Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med (2005) 6.02
Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system. J Clin Endocrinol Metab (2008) 3.64
Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial. Ann Intern Med (2014) 3.48
Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Ann Intern Med (2012) 3.47
Associations between HIV infection and subclinical coronary atherosclerosis. Ann Intern Med (2014) 3.24
Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy. J Clin Oncol (2006) 3.09
Androgen levels in older men who have or who are at risk of acquiring HIV infection. Clin Infect Dis (2005) 2.55
Endogenous sex hormones and glucose tolerance status in postmenopausal women. J Clin Endocrinol Metab (2007) 2.29
Bone disease in HIV infection: a practical review and recommendations for HIV care providers. Clin Infect Dis (2010) 2.20
Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy. Cancer (2006) 2.10
Sex-based differences in pain perception and treatment. Pain Med (2009) 1.82
The association of endogenous sex hormones, adiposity, and insulin resistance with incident diabetes in postmenopausal women. J Clin Endocrinol Metab (2009) 1.71
Long-term effects of androgen deprivation therapy in prostate cancer patients. Clin Endocrinol (Oxf) (2002) 1.64
Incidence and risk factors for steatosis progression in adults coinfected with HIV and hepatitis C virus. Gastroenterology (2010) 1.53
Frailty, HIV infection, and mortality in an aging cohort of injection drug users. PLoS One (2013) 1.46
Lack of an effect of high dose isoflavones in men with prostate cancer undergoing androgen deprivation therapy. J Urol (2009) 1.44
Vitamin D deficiency and persistent proteinuria among HIV-infected and uninfected injection drug users. AIDS (2012) 1.41
Endocrine effects of marijuana. J Clin Pharmacol (2002) 1.35
Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir. AIDS (2012) 1.34
Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia. J Clin Endocrinol Metab (2004) 1.32
Endogenous postmenopausal hormones and serum lipids: the atherosclerosis risk in communities study. J Clin Endocrinol Metab (2004) 1.29
Androgen deficiency, diabetes, and the metabolic syndrome in men. Curr Opin Endocrinol Diabetes Obes (2007) 1.26
Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation. Clin Infect Dis (2013) 1.23
Ultrasonographic measures of cardiovascular disease risk in antiretroviral treatment-naive individuals with HIV infection. AIDS (2013) 1.23
Bone loss in the HIV-infected patient: evidence, clinical implications, and treatment strategies. J Infect Dis (2012) 1.22
Klinefelter syndrome: expanding the phenotype and identifying new research directions. Genet Med (2003) 1.21
Thyroid function abnormalities in HIV-infected patients. Clin Infect Dis (2007) 1.20
Sex hormones, insulin resistance, and diabetes mellitus among men with or at risk for HIV infection. J Acquir Immune Defic Syndr (2011) 1.17
Vitamin D supplementation and endothelial function in vitamin D deficient HIV-infected patients: a randomized placebo-controlled trial. Antivir Ther (2011) 1.14
Association of endogenous sex hormones with diabetes and impaired fasting glucose in men: multi-ethnic study of atherosclerosis. Diabetes Care (2009) 1.14
Effect of highly active antiretroviral therapy on incident AIDS using calendar period as an instrumental variable. Am J Epidemiol (2009) 1.09
Longitudinal increases in waist circumference are associated with HIV-serostatus, independent of antiretroviral therapy. AIDS (2007) 1.09
Male hypogonadism in systemic disease. Endocrinol Metab Clin North Am (2007) 1.09
Depressive symptoms, quality of life, and neuropsychological performance in HIV/AIDS: the impact of gender and injection drug use. J Neurovirol (2005) 1.08
Longitudinal anthropometric changes in HIV-infected and HIV-uninfected men. J Acquir Immune Defic Syndr (2006) 1.07
Free testosterone for hypogonadism assessment in HIV-infected men. Clin Infect Dis (2014) 1.07
Changes in the incidence and predictors of wasting syndrome related to human immunodeficiency virus infection, 1987-1999. Am J Epidemiol (2002) 1.07
Associations of inflammatory markers with AIDS and non-AIDS clinical events after initiation of antiretroviral therapy: AIDS clinical trials group A5224s, a substudy of ACTG A5202. J Acquir Immune Defic Syndr (2014) 1.06
A prospective, randomized clinical trial of antiretroviral therapies on carotid wall thickness. AIDS (2015) 1.05
Relation of stavudine discontinuation to anthropometric changes among HIV-infected women. J Acquir Immune Defic Syndr (2007) 1.02
Management of morphologic changes associated with antiretroviral use in HIV-infected patients. J Acquir Immune Defic Syndr (2008) 1.00
Fat distribution and longitudinal anthropometric changes in HIV-infected men with and without clinical evidence of lipodystrophy and HIV-uninfected controls: a substudy of the Multicenter AIDS Cohort Study. AIDS Res Ther (2009) 0.98
New testosterone buccal system (Striant) delivers physiological testosterone levels: pharmacokinetics study in hypogonadal men. J Clin Endocrinol Metab (2004) 0.97
Age-related skeletal muscle decline is similar in HIV-infected and uninfected individuals. J Gerontol A Biol Sci Med Sci (2011) 0.96
Vitamin D and Calcium Attenuate Bone Loss With Antiretroviral Therapy Initiation: A Randomized Trial. Ann Intern Med (2015) 0.95
Topical testosterone supplementation for the treatment of male hypogonadism. Drugs (2012) 0.94
The prevalence of low sex steroid hormone concentrations in men in the Third National Health and Nutrition Examination Survey (NHANES III). Clin Endocrinol (Oxf) (2011) 0.93
Pharmacokinetic and metabolic effects of American ginseng (Panax quinquefolius) in healthy volunteers receiving the HIV protease inhibitor indinavir. BMC Complement Altern Med (2008) 0.93
Adherence and HIV RNA Suppression in the Current Era of Highly Active Antiretroviral Therapy. J Acquir Immune Defic Syndr (2015) 0.91
Functional impairment, disability, and frailty in adults aging with HIV-infection. Curr HIV/AIDS Rep (2014) 0.91
Prevention strategies for cardiovascular disease in HIV-infected patients. Circulation (2008) 0.91
The effect of androgens on lipids. Curr Opin Endocrinol Diabetes Obes (2013) 0.90
Controlled HIV viral replication, not liver disease severity associated with low bone mineral density in HIV/HCV co-infection. J Hepatol (2011) 0.90
Prevalence of and risk factors for hypoglycemic symptoms after gastric bypass and sleeve gastrectomy. Obesity (Silver Spring) (2015) 0.89
An adapted frailty-related phenotype and the VACS index as predictors of hospitalization and mortality in HIV-infected and uninfected individuals. J Acquir Immune Defic Syndr (2014) 0.88
Gonadal and Adrenal Abnormalities in Drug Users: Cause or Consequence of Drug Use Behavior and Poor Health Outcomes. Am J Infect Dis (2006) 0.88
Accelerated Longitudinal Gait Speed Decline in HIV-Infected Older Men. J Acquir Immune Defic Syndr (2015) 0.88
HAART-associated dyslipidemia varies by biogeographical ancestry in the multicenter AIDS cohort study. AIDS Res Hum Retroviruses (2013) 0.87
Body composition, gender, and illicit drug use in an urban cohort. Am J Drug Alcohol Abuse (2007) 0.87
Lipodystrophy and inflammation predict later grip strength in HIV-infected men: the MACS Body Composition substudy. AIDS Res Hum Retroviruses (2013) 0.87
Relation between duration of androgen deprivation therapy and degree of insulin resistance in men with prostate cancer. Arch Intern Med (2007) 0.86
HIV therapy, metabolic and cardiovascular health are associated with glomerular hyperfiltration among men with and without HIV infection. AIDS (2014) 0.85
Effects of testosterone on body composition of the aging male. Mech Ageing Dev (2004) 0.85
Prevalence of low bone mineral density in a low-income inner-city population. J Bone Miner Res (2011) 0.85
Association of the veterans aging cohort study index with exercise capacity in HIV-infected adults. AIDS Res Hum Retroviruses (2013) 0.84
Nebido: a long-acting injectable testosterone for the treatment of male hypogonadism. Expert Opin Pharmacother (2005) 0.83
Hypothalamic-pituitary-gonadal function in men and women using heroin and cocaine, stratified by HIV status. Gend Med (2007) 0.83
Vitamin D deficiency and its relation to bone mineral density and liver fibrosis in HIV-HCV coinfection. Antivir Ther (2012) 0.83
Serum sex steroid hormones and frailty in older American men of the Third National Health and Nutrition Examination Survey (NHANES III). Aging Male (2012) 0.83
Clinicians' attitudes and usage of complementary and alternative integrative medicine: a survey at the Johns Hopkins Medical Institute. J Altern Complement Med (2007) 0.83
Handedness, functional cerebral hemispheric lateralization, and cognition in male-to-female transsexuals receiving cross-sex hormone treatment. Arch Sex Behav (2005) 0.83
Long acting testosterone undecanoate therapy in men with hypogonadism: results of a pharmacokinetic clinical study. J Urol (2008) 0.83
Changes in metabolic syndrome status after initiation of antiretroviral therapy. J Acquir Immune Defic Syndr (2015) 0.82
Morning free and total testosterone in HIV-infected men: implications for the assessment of hypogonadism. AIDS Res Ther (2014) 0.82
Pharmacokinetics and safety of long-acting testosterone undecanoate injections in hypogonadal men: an 84-week phase III clinical trial. J Androl (2010) 0.82
Testosterone making an entry into the cardiometabolic world. Circulation (2007) 0.82
Lower adiponectin is associated with subclinical cardiovascular disease among HIV-infected men. AIDS (2014) 0.82
Cortisol levels and depression in men and women using heroin and cocaine. Psychoneuroendocrinology (2005) 0.81
Response to Berg et al. 'Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review'. AIDS (2007) 0.81
Elevated HDL cholesterol levels are associated with osteoporosis in lung transplant candidates with chronic obstructive pulmonary disease. Respir Med (2010) 0.81
Inaccuracy of haemoglobin A1c among HIV-infected men: effects of CD4 cell count, antiretroviral therapies and haematological parameters. J Antimicrob Chemother (2014) 0.81
Effect of methyl testosterone administration on plasma viscosity in postmenopausal women. Clin Endocrinol (Oxf) (2002) 0.81
Long-term impact of HIV wasting on physical function. AIDS (2016) 0.81
Long-term body composition changes in antiretroviral-treated HIV-infected individuals. AIDS (2016) 0.80
Association between systemic inflammation and obstructive sleep apnea in men with or at risk for HIV infection. Antivir Ther (2014) 0.80
Current and future testosterone delivery systems for treatment of the hypogonadal male. Expert Opin Drug Deliv (2008) 0.80
Effects of simvastatin, an HMG-CoA reductase inhibitor, in patients with hypertriglyceridemia. Clin Cardiol (2003) 0.79
Adiponectin and interleukin-6, but not adipose tissue, are associated with worse neurocognitive function in HIV-infected men. Antivir Ther (2015) 0.79
Associations between antiretroviral use and subclinical coronary atherosclerosis. AIDS (2016) 0.78
Association between sex steroid hormones and hematocrit in a nationally representative sample of men. J Androl (2012) 0.78